Browsing by Subject "Multilevel intervention"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Correction to: Development and Feasibility Testing of a Multilevel Intervention to Increase Hepatitis C Virus Screening Among Baby Boomers in Primary Care
    (Springer, 2023) Kasting, Monica L.; Laily, Alfu; Nephew, Lauren D.; Shields, Cleveland G.; Shedd‑Steele, Rivienne; Rawl, Susan M.; Medicine, School of Medicine
    Correction to: Journal of Cancer Education 10.1007/s13187-023-02268-x The original version of this article unfortunately contained a mistake. Table 3, p.8 of the article, the header REMINDER LETTER should be replaced with EDUCATIONAL VIDEO. The original article has been corrected.
  • Thumbnail Image
    Item
    Development and Feasibility Testing of a Multilevel Intervention to Increase Hepatitis C Virus Screening Among Baby Boomers in Primary Care
    (Springer, 2023) Kasting, Monica L.; Laily, Alfu; Nephew, Lauren D.; Shields, Cleveland G.; Shedd‑Steele, Rivienne; Rawl, Susan M.; Medicine, School of Medicine
    Chronic infection with hepatitis C virus (HCV) results in an increased risk of cirrhosis and hepatocellular carcinoma (HCC). Only 15% of baby boomers (born 1945–1965) have ever been screened. We aimed to develop a multilevel intervention to increase HCV screening for baby boomers in a primary care setting. This study included two phases: intervention development (phase 1) and feasibility testing (phase 2). In phase 1, we partnered with a Community Advisory Board and a Provider Advisory Board to develop a multilevel intervention to increase HCV screening to be delivered to both providers and patients in primary care. Phase 2 assessed intervention feasibility, acceptability, and usability by conducting Concurrent Think Aloud (CTA) interviews and surveys using previously validated scales with patients (n = 8) and providers (n = 7). Phase 1 results: The patient-level intervention included a mailed reminder letter and CDC pamphlet and a 7-min in-clinic educational video. The provider-level intervention included a 30-min educational session and monthly performance feedback e-mails. Phase 2 results: Qualitatively, both the patient and provider-level intervention were feasible, acceptable, and usable by the target audiences. Quantitatively, on a 1–4 scale, the range of patient-level scores was 3.00–4.00 and provider level was 3.50–4.00 for feasibility, acceptability, and usability. This intervention could improve HCV screening among a high-risk population and therefore reduce HCV-related morbidity and mortality. This project developed a feasible, acceptable, and usable multilevel intervention aimed at increasing HCV screening in primary care.